Skip to main navigation Skip to search Skip to main content

Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis

  • Junshik Hong
  • , Seok Jin Kim*
  • , Jae Sook Ahn
  • , Moo Kon Song
  • , Yu Ri Kim
  • , Ho Sup Lee
  • , Ho Young Yhim
  • , Dok Hyun Yoon
  • , Min Kyoung Kim
  • , Sung Yong Oh
  • , Yong Park
  • , Yeung Chul Mun
  • , Young Rok Do
  • , Hun Mo Ryoo
  • , Je Jung Lee
  • , Jae Hoon Lee
  • , Won Seog Kim
  • , Cheolwon Suh
  • *Corresponding author for this work
  • Gachon University
  • Sungkyunkwan University
  • Chonnam National University
  • Pusan National University
  • Yonsei University
  • Kosin University
  • University of Ulsan
  • Yeungnam University
  • Dong-A University
  • Korea University
  • Ewha Womans University
  • Keimyung University
  • Catholic University of Daegu

Research output: Contribution to journal › Journal article › peer-review

Fingerprint

Dive into the research topics of 'Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science